Tarbox Family Office’s Sage Therapeutics SAGE Stock Holding History

Tarbox Family Office’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-25	Closed	-$1K	–	1130
2021 Q4	$1K	Hold	25	–	–	﹤0.01%	1052
2021 Q3	$1K	Sell	25 -3	-11%	-$138	﹤0.01%	1097
2021 Q2	$2K	Hold	28	–	–	﹤0.01%	973
2021 Q1	$2K	Hold	28	–	–	﹤0.01%	926
2020 Q4	$2K	Hold	28	–	–	﹤0.01%	888
2020 Q3	$2K	Hold	28	–	–	﹤0.01%	835
2020 Q2	$1K	Buy	28 +10	+56%	+$363	﹤0.01%	1047
2020 Q1	$1K	Buy	+18	New	+$1.04K	﹤0.01%	972
2019 Q4	–	Sell	-13	Closed	-$2K	–	1168
2019 Q3	$2K	Hold	13	–	–	﹤0.01%	774
2019 Q2	$2K	Hold	13	–	–	﹤0.01%	784
2019 Q1	$2K	Buy	+13	New	+$1.88K	﹤0.01%	526

Other funds holding SAGE

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Tarbox Family Office's SAGE Position: Q1 2022 in Review

Tarbox Family Office sold out of Sage Therapeutics (SAGE) in Q1 2022, closing a stake of 25 shares — an estimated $1K sold.

Tarbox Family Office first reported a position in SAGE in Q1 2019 and held it in 11 quarters. The position peaked at $2K in Q2 2021. 212 funds tracked by Wall St. Rank hold SAGE as of Q1 2022.

Tarbox Family Office reported no remaining Sage Therapeutics position as of Q1 2022 after selling out during the quarter.
Tarbox Family Office sold 25 Sage Therapeutics shares in Q1 2022, an estimated $1K.
Tarbox Family Office first reported a position in Sage Therapeutics in Q1 2019 and held it in 11 quarters.
Tarbox Family Office's Sage Therapeutics position peaked at $2K in Q2 2021.
212 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2022.

Based on Tarbox Family Office's 13F filing for Q1 2022, filed 25 Apr 2022.